EntryPoint Capital »

Sage Therapeutics shares owned by EntryPoint Capital

Quarter-by-quarter ownership of Sage Therapeutics (SAGE) shares owned by EntryPoint Capital from 13F filings

Historical chart of EntryPoint Capital investment in Sage Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sage Therapeutics held by EntryPoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sage Therapeutics by EntryPoint Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $206k 29k 7.22